LL Capital Corp. Announces Qualifying Transaction

TORONTO, ONTARIO--(Marketwired - April 13, 2015) - LL Capital Corp. ("LL" or the "Corporation") (TSX VENTURE:LLA.P) is pleased to announce that it has entered into a definitive acquisition agreement with Syncordia Technologies and Healthcare Solutions, Inc. ("Syncordia"), pursuant to which LL has agreed to acquire all of the issued and outstanding shares in the capital of Syncordia upon the terms and conditions set out in the agreement (the "Proposed Transaction"). It is currently anticipated that the Proposed Transaction will result in the Syncordia shareholders holding the majority of the outstanding shares of the resulting issuer.

When completed, the Proposed Transaction will constitute LL's qualifying transaction pursuant to the policies of the TSX Venture Exchange (the "TSXV"), and is subject to compliance with all necessary regulatory approvals and certain other terms and conditions. A comprehensive press release with further particulars relating to the Proposed Transaction will follow in accordance with the policies of the TSXV.

Michael Franks, Syncordia's Chief Executive Officer says "the decision to team up with LL Capital is consistent with Syncordia's vision of becoming a world class technology enabled revenue cycle management company utilizing a proprietary suite of software applications to provide best in class solutions."

ABOUT SYNCORDIA TECHNOLOGIES AND HEALTHCARE SOLUTIONS, INC.

Syncordia is a revenue cycle management ("RCM") company providing software and solutions to the healthcare industry. Syncordia is buying medical billing companies with and without proprietary software and building a proprietary suite of RCM software solutions called the Syncordia Cloud, which includes patient scheduling, electronic health records, claims management, analytics and more. Syncordia's ability to not only offer but control the entire product offering of both software and solutions uniquely positions the company to be able to deliver a refreshingly simple and powerful product offering that's largely absent in healthcare today. Syncordia's innovative team currently work out of offices in the United States, Canada, and Ireland.

ABOUT LL CAPITAL CORP.

LL Capital Corp. is a capital pool company formed under the TSXV capital pool company program.

Completion of the proposed transaction is subject to a number of conditions, including but not limited to, TSXV acceptance. There can be no assurance that the transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the filing statement to be prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSXV has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation's filings with the Canadian securities regulators, which filings are available at www.sedar.com.